CD4+ T cells are critical, for corneal, but not skin, allograft rejection

Transplantation

Volumn 69, Issue 4, 2000, Pages 483-487

  Haskova, Zdenka ^a,b   Usiu, Norio ^a   Pepose, Jay S ^a   Ferguson, Thomas A ^a   Stuart, P Michael ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; FEMALE; GRAFT REJECTION; IMMUNE RESPONSE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SKIN TRANSPLANTATION; STEM CELL; T LYMPHOCYTE;

EID: 0034011354     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200002270-00004     Document Type: Article

References (28)

1. Rosenberg AS, Singer A. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992; 10: 333.
2. Burdick JF, Clow LW. Rejection of marine cardiac allografts: I. relative role of major and minor antigens. Transplantation 1986; 42: 67.
3. Wang Y, Mayne A, Sell MK, Ahmed-Ansari A. The influence of MHC, non-MHC on the nature of murine cardiac allograft rejection: I. kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue. Transplantation 1990; 50: 313.
4. He YG, Ross J, Niederkorn J. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci 1991; 32: 2723.
5. Ayliffe W, Alam Y, Bell EB, McLeod D, Hutchinson IV. Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody. Br J Ophthalmol 1992; 76: 602.
6. Pleyer U, Milani JK, Dukes A, et al. Effect of topically applied anti-CD4 monoclonal antibodies on orthotopic corneal allografts in a rat model. Invest Ophthalmol Vis Sci 1995; 36: 52.
7. Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141.
8. Sprent J, Schaefer M, Lo D, Korngold R. Properties of purified T cell subsets: II. in vivo response to class I vs class II H-2 differences. J Exp Med 1986; 165: 1296.
9. Rosenberg AS, Mizuochi T, Sharrow SO, Singer A. Phenotype, specificity and function of T cell subsets and T cell interactions involved in skin allograft rejection. J Exp Med 1987; 165: 1296.
10. + cells are essential for allorejection. J Exp Med 1996; 184: 2013.
11. Krieger NR, Ito H, Fathman CG. Rat pancreatic islet and skin xenograft survival in CD4 and CD8 knockout mice. J Autoimmun 1997; 10: 309.
12. + cells but marked decreased helper cell activity in mice lacking CD4. Nature 1991; 353: 180.
13. Fung-Leung W-P, Schilham MW, Rahemtulla A, et al. CD8 is needed for development of cytotoxic but not helper T cells. Cell 1991; 65: 443.
14. Bonfoco E, Stuart PM, Brunner T, et al. Inducible nonlymphoid expression of Fas-ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity 1998; 9: 711.
15. Joo C-K, Pepose JS, Stuart PM. T-cell mediated responses in a murine model of orthotopic corneal transplantation. Invest Ophthalmol Vis Sci 1995; 36: 1530.
16. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice: evidence that the immunogenetic rules of rejection do not apply. Transplantation 1992; 54: 694.
17. Sano Y, Ksander BR, Streilein JW. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Invest Ophthalmol Vis Sci 1995; 36: 2176.
18. Stuart PM, Melvold RW, Beck-Maier B. Provocation of skin graft rejection across murine class II differences by non-bone-marrow-derived cells. Transplantation 1984; 37: 393.
19. + T cells in respiratory virus infections. J Immunol 154:6013-6021.
20. Coligan FE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds). Current protocols in immunology, Vol. 1, Sec. 3.15, p. 3.15.6. New York, John Wiley, 1991.
21. Sano Y, Ksander BR, Streilein JW. Murine orthotopic corneal transplantation in high-risk eyes: rejection is dictated primarily by weak rather than strong alloantigens. Invest Ophthalmol Vis Sci 1997; 38: 1130.
22. Niederkorn JY, Mayhew E. 'Subthreshold stimulation' of allospecific delayed hypersensitivity by corneal allografts. Immunol 1993; 80: 604.
23. Sonoda Y, Sano Y, Ksander B, Streilein JW. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 1995; 36: 427.
24. Cher DI, Mosmann TR. Two types of murine helper T cell clones: II: delayed-type hypersensitivity is mediated by Th1 clones. J Immunol 1987; 138: 3688.
25. Rosenberg AS, Singer A. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992; 10: 333.
26. Peeler J, Niederkorn J, Matoba A. Corneal allografts induce cytotoxic T cell but not delayed hypersensitivity responses in mice. Invest Ophthalmol Vis Sci 1985; 26: 1516.
27. Callanan D, Peeler J, Niederkorn JY. Characteristics of rejection of orthotopic corneal allografts in the rat. Transplantation 1988; 45: 437.
28. Yamamoto N, Einaga-Naito K, Kuriyama M, Kawada Y, Yoshida R. Cellular basis of skin allograft rejection in mice. Specific lysis of allogeneic skin by non-T cells. Transplantation 1998; 65: 818